CEL-SCI Gelecekteki Büyüme
Future kriter kontrolleri 0/6
CEL-SCI is forecast to grow earnings and revenue by 22.5% and 150% per annum respectively while EPS is expected to grow by 30.6% per annum.
Anahtar bilgiler
22.5%
Kazanç büyüme oranı
30.6%
EPS büyüme oranı
Biotechs kazanç büyümesi | 27.1% |
Gelir büyüme oranı | 150.0% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 04 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
9/30/2026 | 13 | -17 | N/A | N/A | 2 |
9/30/2025 | N/A | -31 | -32 | -29 | 3 |
9/30/2024 | N/A | -39 | -39 | -36 | 3 |
6/30/2024 | N/A | -29 | -19 | -19 | N/A |
3/31/2024 | N/A | -30 | -20 | -20 | N/A |
12/31/2023 | N/A | -31 | -23 | -23 | N/A |
9/30/2023 | N/A | -32 | -23 | -23 | N/A |
6/30/2023 | N/A | -34 | -23 | -23 | N/A |
3/31/2023 | N/A | -35 | -23 | -23 | N/A |
12/31/2022 | N/A | -37 | -19 | -18 | N/A |
9/30/2022 | N/A | -38 | -19 | -18 | N/A |
6/30/2022 | N/A | -37 | -19 | -18 | N/A |
3/31/2022 | N/A | -36 | -21 | -18 | N/A |
12/31/2021 | N/A | -37 | -26 | -20 | N/A |
9/30/2021 | N/A | -37 | -28 | -19 | N/A |
6/30/2021 | 0 | -34 | -27 | -18 | N/A |
3/31/2021 | 0 | -35 | -25 | -16 | N/A |
12/31/2020 | 1 | -33 | -21 | -15 | N/A |
9/30/2020 | 1 | -30 | -18 | -15 | N/A |
6/30/2020 | 1 | -30 | -17 | -16 | N/A |
3/31/2020 | 1 | -32 | -17 | -17 | N/A |
12/31/2019 | 0 | -29 | -17 | -16 | N/A |
9/30/2019 | 0 | -22 | -17 | -16 | N/A |
6/30/2019 | 1 | -32 | -17 | -17 | N/A |
3/31/2019 | 1 | -26 | -15 | -15 | N/A |
12/31/2018 | 1 | -24 | -15 | -15 | N/A |
9/30/2018 | 0 | -32 | -13 | -13 | N/A |
6/30/2018 | 0 | -22 | -13 | -13 | N/A |
3/31/2018 | 0 | -20 | N/A | -13 | N/A |
12/31/2017 | 0 | -24 | N/A | -12 | N/A |
9/30/2017 | N/A | -14 | N/A | -14 | N/A |
6/30/2017 | 0 | -10 | N/A | -17 | N/A |
3/31/2017 | 0 | -10 | N/A | -20 | N/A |
12/31/2016 | 0 | -10 | N/A | -21 | N/A |
9/30/2016 | 0 | -12 | N/A | -23 | N/A |
6/30/2016 | 0 | -20 | N/A | -22 | N/A |
3/31/2016 | 0 | -21 | N/A | -22 | N/A |
12/31/2015 | 1 | -25 | N/A | -24 | N/A |
9/30/2015 | 1 | -35 | N/A | -24 | N/A |
6/30/2015 | 1 | -32 | N/A | -24 | N/A |
3/31/2015 | 0 | -30 | N/A | -24 | N/A |
12/31/2014 | 0 | -31 | N/A | -22 | N/A |
9/30/2014 | 0 | -28 | N/A | -23 | N/A |
6/30/2014 | 0 | -23 | N/A | -21 | N/A |
3/31/2014 | 0 | -25 | N/A | -18 | N/A |
12/31/2013 | 0 | -12 | N/A | -16 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: CVM is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: CVM is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: CVM is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: CVM is forecast to have no revenue next year.
Yüksek Büyüme Geliri: CVM is forecast to have no revenue next year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if CVM's Return on Equity is forecast to be high in 3 years time